ACFN
Acorn Energy, Inc.
ACFN has a slight edge over ASTS overall, supported by stronger valuation and lower modeled downside.
ASTS
AST SpaceMobile, Inc.
ASTS offers stronger fundamentals, but that advantage does not outweigh its weaker overall profile.
ACFN Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Stable | |
| Stable | |
| Strong |
ACFN's balance sheet is currently strong, and its profitability and cash flow are stable, but its revenue is under pressure.
ASTS Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
ASTS's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
ACFN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 6.8x | $5.98 | -61% |
| Current | 17x | $15.25 | — |
| Fair | 36x | $31.99 | +110% |
| Expensive | 61x | $53.68 | +252% |
Historical ranges are pointers, not guarantees.
ACFN's PE is in its cheap range at 17x.
ASTS PE Valuation
ASTS has no meaningful PE right now: it lost money over the past year.
ACFN Forward outlook
There aren't enough analyst estimates for ACFN to show an outlook.
ASTS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect ASTS's losses to grow, with revenue growing. However, they disagree widely on these estimates.
ACFN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $0.88 | -67% |
| Q2 2026 | $0.61 | -79% |
| Q1 2026 | $0.77 | -71% |
| Q4 2025 | $0.99 | -61% |
| Q3 2025 | $2.65 | +464% |
| Q2 2025 | $2.84 | +1395% |
| Q1 2025 | $2.67 | +3238% |
| Q4 2024 | $2.51 | +4920% |
ACFN has the edge over ASTS on earnings quality, reporting a profit while its opponent remains loss making.
ASTS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$2.15 | -$0.91 |
| Q2 2026 | -$2.16 | -$0.27 |
| Q1 2026 | -$1.80 | +$0.19 |
| Q4 2025 | -$1.34 | +$0.61 |
| Q3 2025 | -$1.24 | +$0.88 |
| Q2 2025 | -$1.89 | -$0.64 |
| Q1 2025 | -$1.99 | -$1.01 |
| Q4 2022 | -$0.58 | -$0.21 |
ASTS is still losing money, but far less than before: $2.15 per share over the past year, against $5.76 at its worst in mid-2021.
ACFN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $2.6M | +4.6% |
| Q2 2026 | $2.5M | -29% |
| Q1 2026 | $2.2M | -28% |
| Q4 2025 | $2.4M | -33% |
| Q3 2025 | $2.5M | -19% |
| Q2 2025 | $3.5M | +55% |
| Q1 2025 | $3.1M | +45% |
| Q4 2024 | $3.5M | +57% |
ACFN's revenue has slid since its 2024 peak: $3M last quarter, up 4.6% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 7.3% | +0.9 points |
| Q2 2026 | 15% | -12 points |
| Q1 2026 | -5.8% | -25 points |
| Q4 2025 | 12% | -12 points |
| Q3 2025 | 6.4% | -18 points |
| Q2 2025 | 27% | +16 points |
| Q1 2025 | 20% | +16 points |
| Q4 2024 | 24% | +21 points |
ACFN has the edge over ASTS on profitability, with a higher operating margin.
ASTS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $42.3M | +187% |
| Q2 2026 | $31.5M | +2627% |
| Q1 2026 | $14.7M | +1952% |
| Q4 2025 | $54.3M | +2731% |
| Q3 2025 | $14.7M | +1240% |
| Q2 2025 | $1.2M | +28% |
| Q1 2025 | $718K | +44% |
| Q3 2022 | $4.2M | +70% |
ASTS has the edge over ACFN on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -415% | +694 points |
| Q2 2026 | -948% | +10744 points |
| Q1 2026 | -1686% | +7083 points |
| Q4 2025 | -175% | +2446 points |
| Q3 2025 | -1109% | +4850 points |
| Q2 2025 | -11692% | -4693 points |
| Q1 2025 | -8769% | +2331 points |
| Q4 2024 | -2621% | N/A |
ASTS's operating margin was −415% last quarter, up 694 points from the same quarter a year ago.
ACFN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $999K | +12% |
| Q2 2026 | $224K | -64% |
| Q1 2026 | $53K | -80% |
| Q4 2025 | $295K | +78% |
| Q3 2025 | $895K | +28% |
| Q2 2025 | $629K | +649% |
| Q1 2025 | $271K | +$314K |
| Q4 2024 | $166K | +$460K |
ACFN has the edge over ASTS on cash generation, producing positive trailing cash flow while its opponent burns cash.
ASTS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$464.2M | -$161.4M |
| Q2 2026 | -$694.8M | -$341.1M |
| Q1 2026 | -$309.7M | -$160.7M |
| Q4 2025 | -$330.7M | -$220.3M |
| Q3 2025 | -$302.9M | -$239.1M |
| Q2 2025 | -$353.6M | -$315.3M |
| Q1 2025 | -$149M | -$61.3M |
| Q4 2024 | -$110.5M | -$63.2M |
ASTS has burned cash in almost every quarter: −$1.8B over the past year, against −$916M the year before.
ACFN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.6% | +15K shares |
| 1 year | 0% | +1K shares |
| 3 years | +0.9% | +23K shares |
| 5 years | +2.9% | +72.9K shares |
ACFN has the edge over ASTS on shareholder dilution, with a more favorable share count trend.
ASTS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.4% | +1.1M shares |
| 1 year | +10% | +27.3M shares |
| 3 years | +235% | +211M shares |
| 5 years | +480% | +248M shares |
| Available history | +944% | +271M shares |
ASTS has 300M diluted shares, up 10% from a year ago.
| Quarter | Spent |
|---|---|
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
ACFN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -5.1x | Net Cash |
| Q2 2026 | -5.5x | Net Cash |
| Q1 2026 | -3.1x | Net Cash |
| Q4 2025 | -2.1x | Net Cash |
| Q3 2025 | -1.6x | Net Cash |
| Q2 2025 | -1.0x | Net Cash |
| Q1 2025 | -1.0x | Net Cash |
| Q4 2024 | -1.1x | Net Cash |
ACFN has more cash than debt.
ASTS Net Leverage
ASTS's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
ACFN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 38.7 | Neutral |
| Stochastic | 7.8 | Oversold |
ACFN's weekly RSI is 39 (neutral) and its Stochastic is 8 (oversold).
ASTS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 34.1 | Neutral |
| Stochastic | 11.9 | Oversold |
ASTS's weekly RSI is 34 (neutral) and its Stochastic is 12 (oversold).
ACFN PE vs Technology Sector
| Metric | ACFN | Sector median | Relative |
|---|---|---|---|
| PE | 17x | 28x | 38% below |
| PE % | 29 | 35 | 6 pts below |
ACFN is trading at 17x earnings, a 38% discount to the Technology sector's median of 28x.
ASTS PE vs Technology Sector
ASTS has no meaningful PE right now: it lost money over the past year.
ACFN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $17.6 | 14% below |
| 20 week MA | $18.7 | 19% below |
| 50 week MA | $18.0 | 15% below |
| 100 week MA | $18.8 | 19% below |
| 200 week MA | $13.3 | 15% above |
ACFN has fallen below most of its moving averages, though it's still 15% above its 200-week average.
ASTS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $44.9 | 23% below |
| 20 week MA | $57.1 | 40% below |
| 50 week MA | $75.5 | 54% below |
| 100 week MA | $57.8 | 40% below |
| 200 week MA | $33.6 | 2.8% above |
ASTS has fallen below most of its moving averages, though it's still 2.8% above its 200-week average.
ACFN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $4.80 | $6.72 | +40% |
| 2021 | $6.72 | $8.96 | +33% |
| 2022 | $8.96 | $5.28 | -41% |
| 2023 | $5.28 | $6.09 | +15% |
| 2024 | $6.09 | $18.2 | +199% |
| 2025 | $18.2 | $15.2 | -16% |
| 2026 YTD | $15.2 | $15.3 | +0.3% |
ACFN has the edge over ASTS on returns for 2026, with the stronger performance.
ASTS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.87 | $13.4 | +36% |
| 2021 | $13.4 | $8.71 | -35% |
| 2022 | $8.71 | $3.97 | -54% |
| 2023 | $3.97 | $6.03 | +52% |
| 2024 | $6.03 | $22.9 | +280% |
| 2025 | $22.9 | $72.0 | +214% |
| 2026 YTD | $72.0 | $34.5 | -52% |
ASTS's yearly returns have swung widely, from +280% in 2024 to −54% in 2022. It's down 52% so far in 2026.